| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |